my portfolios	close
my watchlists

Add to Portfolio - Step 1 of 3	Add to Watchlist - Step 1 of 3!	close
add to a new portfolio	add to a new watchlist

Add to Portfolio - Step 1 of 3	Add to Watchlist - Step 1 of 3!	close
add to a new portfolio	add to a new watchlist

Other symbols	close
Name	Symbol	Exchange	Last Trade	Change
VERTEX PHARMACEUTICALS INC. Registered Sha.	VX1	FSE	€ 27.47	+0.33 (+1.22%)
Vertex Pharmaceuticals Incorporated	VRTX	NAS	$ 37.95	+0.53 (+1.42%)

Vertex Pharma reinitiated with "neutral"

10/21/09 - Wedbush Morgan Securities

NEW YORK, October 21 (newratings.com) - Analysts at Wedbush Morgan reinitiate coverage of Vertex Pharma (VRTX) with a "neutral" rating. The target price is set to $42.

Get the full coverage! What do all 3 analysts say? overview...
VRTX | avg. rating: 66.67% | avg. target price: $ 46.67

Recommend this article to a friend add VRTX to my stocks and get e-mail alerts on Vertex Pharmaceuticals

Latest actions		previous \| next
02/01/10	Vertex Pharmaceuticals upgraded to "outperform"	Oppenheimer
01/19/10	Vertex Pharmaceuticals "outperform," target price raised	RBC Capital Markets
01/05/10	Vertex Pharmaceuticals downgraded to "underperform"	Wedbush Morgan Securities
more ...

www.newratings.com - full analyst coverage

Vertex Pharmaceuticals

$ 37.95 +0.53 (+1.42%)

Vertex Pharma reinitiated with "neutral"

10/21/09 - Wedbush Morgan Securities